There is growing interest in using pharmacologic supplements to combat cancer-related sarcopenia and cachexia, including amino acids, anabolic steroids, anti-inflammatory agents, and ghrelin-analogues, to counteract the deranged metabolism experienced by cancer patients. The gene discussed is GHRL; the disease is cancer.